Randomized Study of Nitazoxanide-Peginterferon, Nitazoxanide-Peginterferon-Ribavirin and Peginterferon-Ribavirin in the Treatment of Chronic Hepatitis C

Trial Profile

Randomized Study of Nitazoxanide-Peginterferon, Nitazoxanide-Peginterferon-Ribavirin and Peginterferon-Ribavirin in the Treatment of Chronic Hepatitis C

Completed
Phase of Trial: Phase II/III

Latest Information Update: 01 Mar 2009

At a glance

  • Drugs Nitazoxanide; Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms STEALTHC-1
  • Sponsors Romark Laboratories
  • Most Recent Events

    • 01 Mar 2009 Results published in Gastroenterology.
    • 23 Sep 2008 Status changed from active, no longer recruiting to completed.
    • 18 Apr 2008 Final results will be presented at EASL 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top